INTRODUCTION
============

RNA editing is a process in which the nucleotide sequences of transcripts are changed by insertion/deletion or conversion of nucleotides, and various types of RNA editing have been found in diverse organisms ([@B1],[@B2]). In the organelles of vascular plants, specific C residues on the transcripts are converted to U, and U-to-C editing rarely occurs ([@B1],[@B3],[@B4]). Chloroplast and mitochondrial genomes of higher plants have 20--40 and 400--500 RNA editing sites, respectively, and in most cases, RNA editing restores phylogenetically conserved codons ([@B1],[@B3],[@B4]), including those of functional importance ([@B5; @B6; @B7; @B8]). Therefore, RNA editing is an indispensable process for plant organellar genomes to produce functional proteins.

An intriguing issue of plant organellar RNA editing is the mechanism by which specific C residues are recognized for editing substrates, since no consensus motif or secondary structure is found in the vicinity of the editing sites. With the aid of transplastomic plants and of *in vitro* RNA editing systems from chloroplast lysates, *cis*-sequences required for RNA editing were analyzed for several tobacco chloroplast editing sites and revealed that *cis*-elements are generally located within 20 nucleotides upstream of the editing sites ([@B9; @B10; @B11; @B12; @B13; @B14; @B15; @B16; @B17]). Proteinous *trans*-acting factors that specifically bind to the *cis*-elements were evidenced by UV-crosslinking experiments with *in vitro* RNA editing systems; *cis*-elements of tobacco *psbL, psbE* and *petB* editing sites are bound by the proteins of 25, 57 and 70 kDa, respectively ([@B12],[@B14],[@B15]). From the study of an *Arabidopsis* mutant deficient in the editing activity of the ndhD-1 site, a site-specific RNA-binding protein, CRR4, was identified ([@B8]). CRR4 is a member of the pentatricopeptide repeat (PPR) family ([@B18]) and specifically binds to the immediate upstream region of the ndhD-1 editing site ([@B19]). PPR proteins constitute an extraordinarily large family in higher plants, and many are involved in the maturation processes of organellar transcripts ([@B20]). As CRR4 does not have a catalytic domain, it is likely to recruit a catalytic subunit of unknown identity to the editing site ([@B8],[@B19]).

The above findings suggest that sequence-specific binding of the *trans*-acting factors to the upstream *cis*-elements is a crucial process of the accurate site recognition of chloroplast RNA editing. If so, how specifically do the *trans*-acting factors recognize their respective *cis*-elements? Site recognition mechanisms of RNA editing seem analogous between chloroplasts and mitochondria ([@B21; @B22; @B23; @B24; @B25; @B26]). If so, how many *trans*-acting factors are necessary to recognize whole editing sites of plant organelles? Overexpression of the *psbL* editing site in tobacco chloroplasts reduced the editing efficiency of endogenous *psbL* mRNA, but not of the other editing sites, implying that the *psbL*-specific *trans*-acting factor is exclusively recruited to the *psbL* editing site ([@B27]). As mentioned above, *trans*-acting factors specifically binding to tobacco *psbL, psbE, petB*, and *Arabidopsis* ndhD-1 editing sites have distinct molecular masses ([@B8],[@B12],[@B14],[@B15]). These genetic and biochemical observations might support a 'one factor to one site' hypothesis for plant organellar RNA editing. However, this hypothesis is now challenged from other viewpoints. The *Arabidopsis* genome encodes ca. 450 PPR proteins ([@B20]), while the total number of chloroplast and mitochondrial editing sites of this plant amounts to more than 480 ([@B28; @B29; @B30]). If *trans*-acting factors responsible for site recognition are exclusively PPR proteins, 'one factor to plural sites' could also be the case. Chateigner-Boutin and Hanson proposed the 'one factor to plural sites hypothesis' on the basis of their observations with transplastomic plants; overexpression of the rpoB-2 or ndhF-2 editing sites reduced the editing efficiencies of several sites ([@B31]). However, the 'one factor to plural sites hypothesis' has not been proven by biochemical investigations.

This study attempted to verify the 'one factor to plural sites' hypothesis on the basis of biochemical analysis. We first compared the molecular masses of *trans*-acting factors specifically binding to several tobacco chloroplast editing sites by UV-crosslinking and sodium dodecyl sulfate--polyacrylamide gel electrophoresis (SDS--PAGE), and found that those of the ndhB-9 and ndhF-1 editing sites seem to be very similar. Next, we examined the identities of ndhB-9 and ndhF-1-specific *trans*-acting factors by cross-competition experiments in the *in vitro* RNA editing system of tobacco chloroplast extracts. The results unequivocally showed that the ndhB-9 and ndhF-1 editing sites are recognized by the same *trans*-acting factor. This is the first clear demonstration that 'one factor to plural sites' recognition operates in plant organellar RNA editing. Sequence identity in the *trans*-factor-binding regions of ndhB-9 and ndhF-1 (−15 to −1 relative to the editing site as +1) is only 60%. On the basis of this finding, we discuss how plant organellar RNA editing sites have propagated and diverged during evolution.

MATERIALS AND METHODS
=====================

Preparation of RNA substrates
-----------------------------

The region from −120 to +21 (relative to the editing site as +1) from the gene of interest, with a 5′ extension of a 20 nt sequence complementary to the T3 primer and a 3′ extension of a 17 nt sequence complementary to the KS primer, was amplified by PCR on plasmids from a tobacco chloroplast DNA clone bank ([@B32]) using gene-specific primer pairs ([Table 1](#T1){ref-type="table"}, PCR forward and PCR reverse). The amplified fragments were cloned into a pGEM-T vector using the pGEM-T Vector System (Promega). From these cloned plasmids, RNA substrates for in vitro editing and UV-crosslinking were prepared as previously described ([@B14]) with slight modifications. The upstream region of the respective genes was amplified from the plasmids by PCR using gene-specific primer pairs ([Table 1](#T1){ref-type="table"}, PCR forward and PCR upstream reverse), and subjected to RNA synthesis with the MEGAscript T3 Kit (Ambion) with purification according to the manufacturer\'s instruction. The 5′ terminal two nucleotides of the PCR upstream reverse primers were ribose 2′-methoxy analogs, which hamper nontemplated nucleotide addition by T3 RNA polymerase ([@B33]). \[5′-^32^P\]-labeled downstream RNAs (20 pmol) ([Table 1](#T1){ref-type="table"}) were ligated to 60 pmol of the corresponding upstream RNAs (113--123 nt) with the aid of 40 pmol of a bridging DNA oligonucleotide ([Table 1](#T1){ref-type="table"}) and T4 DNA ligase in 30 μl reaction mixtures at 30°C overnight. The ligated mRNAs were purified by 5% PAGE containing 7 M urea. When mutations were introduced to the RNA substrates, plasmid clones containing respective chloroplast genes were mutagenized using pairs of mutagenesis primers ([Table 1](#T1){ref-type="table"}) and the QuickChange Site-Directed Mutagenesis Kit (Stratagene), followed by the preparation of RNA substrates as described above. Table 1.Oligononucleotide primers used in this studyNameSequence (5′--3′)PurposeT3+ndhB-2ForAATTAACCCTCACTAAAGGGTAGAGTACATTGAATGTACAPCR forwardT3+ndhB-9ForAATTAACCCTCACTAAAGGGTAATGACTGGACGAAACCAAPCR forwardT3+ndhF-lForAATTAACCCTCACTAAAGGGACCTGTCTATTCAGCAAATAPCR forwardT3+rpoA-lForAATTAACCCTCACTAAAGGGTATATTTACAGGACAATCAAPCR forwardT3+rpoB-lForAATTAACCCTCACTAAAGGGCACTCACATATTCTTCTGAAPCR forwardT3+rpoB-4ForAATTAACCCTCACTAAAGGGCTCGGGGTAAATGCATTAAAPCR forwardT3+vectorForAATTAACCCTCACTAAAGGGTAAGACACGACTTATCGCCAPCR forwardKS+ndhB-2RevTCGAGGTCGACGGTATCAGCATAAACTGAAACATTCTPCR reverseKS+ndhB-9RevTCGAGGTCGACGGTATCTTGGGTTCATTGATATTCCTPCR reverseKS+ndhF-lRevTCGAGGTCGACGGTAICCAACCGTAGTGATTAATAITPCR reverseKS+rpoA- 1RevTCGAGGTCGACGGTATCAGATCCTGGAAGGCAATTCTPCR reverseKS+rpoB-lRevTCGAGGTCGACGGTATCTATATATTCCATTGACTATAPCR reverseKS+rpoB-4RevTCGAGGTCGACGGTATCTAATAAGTACTGCATCTTCAPCR reversevectorRevGGTAACTGGCTTCAGCAGAGPCR reversendhB-9MlGAGTATGATTGTATGTGTGAATCGTTCTACTATACCAGGAATATCPCR mutagenesisndhB-9MlCGATATTCCTGGTATAGTAGAACGATTCACACATACAATCATACTCPCR mutagenesisndhB-9M2TGATTGTATGTGTGATAGCAAGAIGTATACCAGGAATATCAAIGAPCR mutagenesisndhB-9M2CTCATTGATATTCCTGGTATACATCTTGCTATCACACATACAATCAPCR mutagenesisndhB-9M3GTATGTGTGATAGCATCTACATATGCAGGAATATCAATGAACCCAPCR mutagenesisndhB-9M3CTGGGTTCATTGATATTCCTGCATATGTAGATGCTATCACACATACPCR mutagenesisndhF-lMlCGGATACTTGATCGACCCACAATGATCTATTATGTCAATATTAATPCR mutagenesisndhF-lM1CATTAATATTGACATAATAGATCATTGTGGGTCGATCAAGTATCCGPCR mutagenesisndhF-lM2ACTTGATCGACCCACTTACTAGATATATGTCAATATTAATCACTAPCR mutagenesisndhF-lM2CTAGTGATTAATATTGACATATATCTAGTAAGTGGGTCGATCAAGTPCR mutagenesisndhF-lM3ATCGACCCACITACTTCTATATACACAATATTAATCACTACGGITPCR mutagenesisndhF-lM3CAACCGTAGTGATTAATATTGTGTATATAGAAGTAAGTGGGTCGATPCR mutagenesisndhB-2(+l)AGCATAAACTGAAACATTCTGGGGCTACAAAGATAGTTATTBridge DNAndhB-9(+l)TTGGGTTCATTGATATTCCTGGTATAGTAGATGCTATCACABridge DNAndhB-9(−10)GATATTCCTGGTATAGTAGATGCTATCACACATACAATCABridge DNAndhF-l(+l)CAACCGTAGTGATTAATATTGACATAATAGAAGTAAGTGGGBridge DNAndhF-l(−l0)ATTAATATTGACATAATAGAAGTAAGTGGGTCGATCAAGTBridge DNArpoA-l(+l)AGATCCTGGAAGGCAATTCTGATTGGTCAATAAAAATCGATBridge DNArpoB-l(+l)TATATATTCCATTGACTATAGAAGTTCCCAGGGAATTCATTBridge DNArpoB-4(+l)TAATAAGTACTGCATCTTCAGAATTGTAACCCTCCCACGGCBridge DNAndhB-2(+l)Rev[GG]{.ul}GCTACAAAGATAGTTATTAAPCR upstream reversendhB-9(+l)Rev[GU]{.ul}ATAGTAGATGCTATCACACAPCR upstream reversendhB-9(−10)Rev[UG]{.ul}CTATCACACATACAATCATAPCR upstream reversendhF-l(+l)Rev[AC]{.ul}ATAATAGAAGTAAGTGGGTCPCR upstream reversendhF-l(−10)Rev[AG]{.ul}TAAGTGGGTCGATCAAGTATPCR upstream reverserpoA-l(+l)Rev[AU]{.ul}TGGTCAATAAAAATCGATTTPCR upstream reverserpoB-l(+l)Rev[AA]{.ul}GTTCCCAGGGAATTCATTAGPCR upstream reverserpoB-4(+l)Rev[AA]{.ul}TTGTAACCCTCCCACGGCATPCR upstream reversendhB-2(+l)CAGAAUGUUUCAGUUUAUGCUGAUACCGUCGACCUCGADownstream RNAndhB-9(+l)CAGGAAUAUCAAUGAACCCAAGAUACCGUCGACCUCGADownstream RNAndhB-9(−10)UCUACUAUACCAGGAAUAUCDownstream RNAndhF-l(+l)CAAUAUUAAUCACUACGGUUGGAUACCGUCGACCUCGADownstream RNAndhF-l(−l0)UCUAUUAUGUCAAUAUUAAUDownstream RNArpoA-l(+l)CAGAAUUGCCUUCCAGGAUCUGAUACCGUCGACCUCGADownstream RNArpoB-l(+l)CUAUAGUCAAUGGAAUAUAUAGAUACCGUCGACCUCGADownstream RNArpoB-4(+l)CUGAAGAUGCAGUACUUAUUAGAUACCGUCGACCUCGADownstream RNA[^1]

Preparation of chloroplast extracts
-----------------------------------

Chloroplast extracts were prepared from tobacco leaves as previously described ([@B34]), and utilized for RNA editing reactions and UV-crosslinking.

*In vitro* RNA editing and UV-crosslinking
------------------------------------------

RNA editing and UV-crosslinking assays were carried out essentially as previously described ([@B15]), with slight modifications. Both reaction mixtures contained 4 μl of chloroplast extract (∼50 μg protein) and 10 fmol of mRNA substrate. For RNA editing assays, an mRNA substrate was incubated at 28°C for 1 h. RNA was isolated and digested into 5′ mononucleotides with 1 U of nuclease P1 (Wako) and 120 U of S1 nuclease (TaKaRa) in the presence of 50 mM ammonium acetate (pH 4.8) at 37°C for 3 h. Mononucleotides were separated on cellulose TLC plates (FC-2020, Funakoshi) using isopropanol:HCl:water (70:15:15). For UV-crosslinking assays, an mRNA substrate was incubated at 28°C for 1 h in the editing mixture. Reaction mixtures were irradiated with UV light (254 nm, 1.0 J/cm^2^) at approximately 10 cm distance using a Funacrosslinker (Funakoshi), then subjected to RNA digestion by 100 ng of RNase A at 37°C for 1 h. Protein samples were separated by 7.5% PAGE containing 0.1% SDS. ^32^P-labeled mononucleotides on TLC and ^32^P-crosslinked proteins on PAGE were visualized by STORM (GE Healthcare).

Nomenclature for RNA editing sites
----------------------------------

The chloroplast genome of tobacco (*Nicotiana tabacum*) is known to have 38 RNA editing sites ([@B34; @B35; @B36; @B37]). In this study, the editing sites of tobacco are simply denoted as, for example, ndhB-9 that means the ninth editing site of tobacco *ndhB* mRNA counted from the 5′ end. However, ndhF-1 site in this nomenclature corresponds to ndhF2 of the previous reports ([@B31],[@B35]) that name was given based on the comparison between tobacco and maize. For circumventing the confusion, the editing sites examined in this study are more precisely defined in [Table 2](#T2){ref-type="table"}, following the universal nomenclature used by Heyes *et al.* ([@B16]); NTndhB C141 means the editing site at the 141st C of the *ndhB* mRNA of *Nicotiana tabacum*. Table 2.*trans*-acting factors for cloroplast RNA editing, listed in the decreasing order of apparent molecular massEditing siteMolecular massDetectionReferencesNTndhB C148195 kDaUV crosslinkThis study (ndhB-9)NTndhF C29095 kDaUV crosslinkThis study (ndhF-1)NTrpoA C68093 kDaUV crosslinkThis study (rpoA-1)NTrpoB C33891 kDaUV crosslinkThis study (rpoB-1)NTrpoB C200076 kDaUV crosslinkThis study (rpoB-4)NTpetB C61170 kDaUV crosslink([@B14],[@B15])PSpetB C61170 kDaUV crosslink([@B14])ATndhD C268 kDaCRR4 gene([@B8])NTndhB C46759 kDaUV crosslinkThis study (ndhB-2)NTpsbE C21456 kDaUV crosslink([@B14],[@B15])NTpsbL C225 kDaUV crosslink([@B31])[^2]

RESULTS
=======

Both ndhB-9 and ndh-F1 editing sites are crosslinked with 95 kDa protein
------------------------------------------------------------------------

The tobacco chloroplast genome is known to have 38 RNA editing sites ([@B34; @B35; @B36; @B37]). We previously showed for tobacco psbE-1 and petB-1 RNA editing sites that the proteinous site-specific factors are UV-crosslinked with their respective editing sites (C at +1), as well as the cognate upstream *cis*-elements ([@B15]). If this is also the case for the rest of the RNA editing sites, we could detect and compare the molecular sizes of the respective site-specific factors by specific labeling of the C at +1 and subsequent UV-crosslinking. Therefore, we first examined the RNA editing efficiencies of 36 tobacco editing sites in our *in vitro* RNA editing system (Kobayashi *et al.* will be submitted elsewhere), and picked up six editing sites that exhibited relatively high editing efficiency. Next, we carried out UV-crosslinking experiments for these six editing sites using the RNA substrates (from −120 to +21) labeled at +1 with ^32^P, and with tobacco chloroplast extracts that favor *in vitro* editing reactions. After crosslinking, RNA molecules that were not crosslinked with the proteins were digested by RNase, followed by SDS--PAGE. [Figure 1](#F1){ref-type="fig"} shows autoradiograms of the proteins that were crosslinked with the editing sites (+1). To discriminate specific binding proteins from nonspecific binding proteins, we added either a 100-fold molar excess of the same RNA (lanes 2 in each panel in [Figure 1](#F1){ref-type="fig"}A) or the exogenous control RNA (lanes 3 in [Figure 1](#F1){ref-type="fig"}A) as competitors. This treatment revealed the proteins that specifically bind to the editing sites, and [Figure 1](#F1){ref-type="fig"}A denotes their apparent molecular masses (e.g. the 59 kDa protein is denoted as p59); these factors are summarized in [Table 2](#T2){ref-type="table"} in comparison with those of previously reported factors. Among them, proteins specifically binding to the ndhB-9 and ndhF-1 editing sites especially attracted our attention, because their molecular masses appeared to be both 95 kDa. As such, we compared their electrophoretic mobilities on SDS--PAGE once again in adjoining lanes and after a long distance run. However, we could not find any difference between them ([Figure 1](#F1){ref-type="fig"}B). This hints at the possibility that p95s of ndhB-9 and ndhF-1 may be either the same or structurally similar proteins. In the following study, we investigate this possibility by examining the biochemical properties of these proteins. Figure 1.*Trans*-acting factors specifically binding to the editing sites in the extracts of tobacco chloroplasts. (**A**) UV-crosslinking was performed with a respective RNA probe that was labeled with ^32^P at +1 (C to be edited). Lanes 1, without competitor RNA; lanes 2, a 100-fold molar excess of unlabeled probe RNA was added as a competitor; lanes 3, a 100-fold molar excess of control RNA that was a 161 nt transcript of a pGEM-T vector was added as a competitor. Free indicates the bands of a free probe that migrated in front of the protein bands on SDS--PAGE. (**B**) Comparison of the electrophoretic mobilities of p95s binding to ndhB-9 (lane 1) and ndhF-1 (lane 2).

The 95 kDa proteins are *trans*-acting factors for RNA editing
--------------------------------------------------------------

To ensure that the p95s are involved in RNA editing, we examined the correlation between the RNA editing activity and the binding of p95s to their respective RNA editing sites. Here, we introduced 5 nt scanning mutations to the −15 to −1 regions of the ndhB-9 and ndhF-1 RNA substrates (−120 to +21) as shown in [Figure 2](#F2){ref-type="fig"}A and D, respectively, and then supplemented them to an *in vitro* RNA editing system as competitors. Figure 2.*In vitro* analysis of the RNA editing and the binding of p95s in the presence of mutated competitors. (**A**) and (**D**) represent the competitors derived from the ndhB-9 and ndhF-1 sequences, respectively. (**B**) and (**E**) represent RNA editing profiles of the ndhB-9 and ndhF-1 substrates, respectively, in the presence of various competitors. (**C**) and (**F**) represent binding profiles of p95s to the ndhB-9 and ndhF-1 probes, respectively. In (B) and (C): lanes 1, without competitor; lanes 2, with control competitor as was used in [Figure 1](#F1){ref-type="fig"}; lanes 3--6, BW, BM1, BM2, and BM3 were added as competitors, respectively. In (E) and (F): lanes 1, without competitor; lanes 2, with control competitor as in [Figure 1](#F1){ref-type="fig"}; lanes 3--6, FW, FM1, FM2, and FM3 were added as competitors, respectively.

When wild-type substrates (BW and FW in [Figure 2](#F2){ref-type="fig"}) were added as competitors in a 100-fold molar excess, they trapped the respective *trans*-acting factors, causing the disappearance of C-to-U RNA editing (lanes 3 in [Figure 2](#F2){ref-type="fig"}B and E) as well as the UV-crosslinking signals (lanes 3 in [Figure 2](#F2){ref-type="fig"}C and F). Under the same conditions, mutations spanning −15 to −11 (BM1 and FM1) and --10 to --6 (BM2 and FM2) canceled competition, resulting in the appearance of radiolabeled signals for C-to-U RNA editing (lanes 4 and 5 in [Figure 2](#F2){ref-type="fig"}B and E) and UV-crosslinking (lanes 4 and 5 in [Figure 2](#F2){ref-type="fig"}C and F). These indicate that the upstream sequences from −15 to −6 are essential for recruiting *trans*-acting factors that ensure RNA editing reactions, as well as the contact of p95s to the C at +1. Interestingly, mutations introduced into the region from −5 to −1 (BM3 and FM3 in [Figure 2](#F2){ref-type="fig"}) did not cancel the competition. Rather, they weakened it, resulting in weak detections of both RNA editing and p95s' binding signals (lanes 6 in [Figure 2](#F2){ref-type="fig"}). Therefore, RNA editing activity and the binding of p95s to the editing sites were well correlated over the mutations scanning from --15 to --1 for both the ndhB-9 and ndhF-1 editing sites. These correlations strongly suggest that p95s are *trans*-acting factors indispensable for RNA editing.

We previously reported for tobacco psbE-1 and petB-1 RNA editing sites that the site-specific *trans*-acting factors are recruited to the upstream *cis*-elements and then interact with the C residue (+1) to be edited ([@B15]). In order to test whether p95s are *trans*-acting factors with similar properties, we examined if p95s bind to the upstream *cis*-elements. As described above, *cis*-elements of the ndhB-9 and ndhF-1 editing sites that recruit *trans*-acting factors are located in the region from −15 to −6 ([Figure 2](#F2){ref-type="fig"}). Thus, we introduced radiolabels at −10, in the midst of the respective *cis*-elements ([Figure 3](#F3){ref-type="fig"}A and C, asterisk), and the resultant RNA probes were subjected to UV-crosslinking experiments. [Figure 3](#F3){ref-type="fig"}B represents SDS--PAGE profiles of the proteins bound to --10 and +1 of the ndhB-9 editing site, and [Figure 3](#F3){ref-type="fig"}D represents those of the ndhF-1 site. For both editing sites, p95s appeared to be specifically bound with upstream *cis*-elements (−10) as well as to the editing sites (+1). As for −10 of the ndhF-1 site, another crosslinked signal was detected on SDS--PAGE with an apparent molecular mass slightly larger than that of p95 ([Figure 3](#F3){ref-type="fig"}D). However, this binding signal appeared to be nonspecific, because it did not disappear when a homologous competitor was added in excess ([Figure 3](#F3){ref-type="fig"}D, lane 2). Figure 3.Detection of *trans*-acting factors by UV-crosslinking with ndhB-9 and ndhF-1 RNAs labeled with ^32^P at −10 and +1 relative to the editing site. (**A**) and (**C**) represent RNA probes of ndhB-9 and ndhF-1, respectively. Asterisks indicate labeled nucleotides. (**B**) and (**D**) represent UV-crosslinking profiles for ndhB-9 and ndhF-1, respectively. Lanes 1, without competitor; lanes 2, a 100-fold molar excess of unlabeled probe RNA was added as a competitor; lanes 3, a 100-fold molar excess of control RNA as in [Figure 1](#F1){ref-type="fig"} was added as a competitor.

Taken together with these results, we conclude that the p95s are site-specific *trans*-acting factors for the ndhB-9 and ndhF-1 RNA editing sites, and that they are recruited by the upstream *cis*-elements (from −15 to −6) and then interact with the editing site (+1) similarly to p56, the *trans*-acting factor of the psbE-1 editing site ([@B15]). However, the relationship between these two p95s that specifically bind to ndhB-9 or ndhF-1 is still unknown.

P95 recognizes both ndhB-9 and ndh-F1 editing sites
---------------------------------------------------

To clarify whether a given p95 can specifically bind to either or both of the ndhB-9 and ndh-F1 editing sites, we tested the binding specificity of the p95s to these sites by a cross-competition experiment ([Figure 4](#F4){ref-type="fig"}). Figure 4.Cross-competition experiments between ndhB-9 and ndhF-1 RNAs. (**A**) Competitor sequences. (**B**) and (**D**) represent RNA editing profiles of the ndhB-9 and ndhF-1 substrates, respectively, in the presence of various competitors. (**C**) and (**E**) represent the binding profiles of p95s to the ndhB-9 and ndhF-1 RNAs, respectively. Lanes 1, without competitor; lanes 2--5, BW, BM2, FW, and FM2 were added as competitors, respectively.

First, we tested whether the p95 that specifically binds to the ndhB-9 site could also recognize the ndhF-1 site with the aid of ndhB-9 RNA (−120 to +21) radiolabeled at +1 as a probe. As was expected from [Figure 2](#F2){ref-type="fig"}, RNA editing activity ([Figure 4](#F4){ref-type="fig"}B) and the binding of p95 ([Figure 4](#F4){ref-type="fig"}C) to the ndhB-9 site were both inhibited by the addition of the same RNA (BW) as a competitor (lanes 2), but not by BM2, which was mutated on the p95 binding site (lanes 3). Surprisingly, similar results were obtained when FW (−120 to +21 of the ndhF-1 site) and FM2 (the same as FW, but the *cis*-element was mutated) were added as competitors: FW inhibited both RNA editing and the binding of p95 to the ndhB-9 site (lanes 4), but FM2 did not (lanes 5). This result indicates that the p95 that specifically binds to the ndhB-9 site can also bind to ndhF-1 in a sequence-specific manner.

Next, we examined the reverse case, using the ndhF-1 RNA (−120 to +21) as a probe. The obtained results are shown in [Figure 4](#F4){ref-type="fig"}D and E, indicating that the p95 that specifically binds to the ndhF-1site can also recognize the ndhB-9 site.

These complementary results let us conclude that the ndhB-9 and ndhF-1 RNA editing sites are corecognized by the identical *trans*-acting factor, p95.

DISCUSSION
==========

This study demonstrated that the C residues at six RNA editing sites of tobacco chloroplast RNAs are bound by their respective site-specific proteins ([Figure 1](#F1){ref-type="fig"}). [Table 2](#T2){ref-type="table"} summarizes their apparent molecular masses in comparison with those previously reported for other editing sites ([@B8],[@B12],[@B14],[@B15]). The molecular masses distribute from 25 to 95 kDa, implying that the site-specific factors have molecular diversity. CRR4, which specifically binds to the immediate upstream region of the ndhD-1 site in *Arabidopsis thaliana*, is a member of the PPR protein family ([@B18],[@B20]), and CRR4 contains 10 PPR motifs ([@B8],[@B19]). If site-specific factors detected by UV-crosslinking are all PPR proteins, they might differ in the number of PPR motifs in conjunction with their specificity to the binding sequences ([@B38]).

Competition experiments for ndhB-9 and ndhF-1 RNA editing sites ([Figure 2](#F2){ref-type="fig"}) showed that site-specific *trans*-acting factors are recruited by their respective upstream *cis*-elements located from −15 to −6 in a sequence-specific manner, and that a close proximity (−5 to −1) has a weak effect on these interactions. These results are in accordance with previously proposed models for the site recognition of chloroplast RNA editing ([@B9],[@B10],[@B12],[@B14],[@B15],[@B39]).

The most notable finding in this study is that the ndhB-9 and ndhF-1 RNA editing sites are recognized by the same *trans*-acting factor. This conclusion was obtained from cross-competition experiments between ndhB-9 and ndhF-1 RNAs in the *in vitro* RNA editing and p95-binding reactions ([Figure 4](#F4){ref-type="fig"}). As shown in [Figure 5](#F5){ref-type="fig"}A, the upstream regions (−15 to −1) of ndhB-9 and ndhF-1 represent a 60% identity in nucleotide sequence. This implies that a given *trans*-acting factor of chloroplast RNA editing could recognize groups of *cis*-elements that share moderate sequence identity. From this view, we reexamined the 38 RNA editing sites of the tobacco chloroplast genome to search for possible candidates recognized by common *trans*-acting factors. As shown in [Figure 5](#F5){ref-type="fig"}B, six pairs of editing sites were found to have 60% or higher identity in their upstream sequences (−15 to −1) in addition to ndhB-9 and ndhF-1. If these pairs are really recognized by respective common factors, only 31 site-specific factors could be enough to account for 38 editing sites. Figure 5.Comparison of the nucleotide sequences in the upstream regions (−15 to +1) of tobacco chloroplast editing sites. (**A**) Comparison between ndhB-9 and ndhF-1. (**B**) Pairs of the editing sites that exhibit 60% or higher sequence identity.

In transplastomic tobacco plants, overexpression of the ndhF-1 editing site caused a decrease in editing efficiency in endogenous ndhF-1, ndhB-3 and ndhD-1 sites, but not in the other sites (31; ndhF-1 site was mentioned as ndhF-2 in this reference; see Materials and Methods). This appears to imply that ndhF-1 editing site shares *trans*-acting factor(s) with ndhB-3 and ndhD-1 sites but not with ndhB-9 site. However, the present study demonstrated that ndhF-1 and ndhB-9 share the site-recognition factor of 95 kDa. Why was cosuppression not observed for ndhF-1 and ndhB-9 in the transplastomic plants? The putative *cis*-acting regions of ndhF-1, ndhB-3 and ndhD-1 do not share sequence identity until gaps are introduced. In plant organellar RNA editing, spacing between upstream *cis*-elements and editing sites was shown to be critical, with only one base insertion/deletion in such a region causing the complete loss of editing activity ([@B17],[@B22],[@B39]). Therefore, one possibility might be that the above cosuppression phenotype in transplastomic plants was caused by competition for some unknown factors other than site recognition protein. In accordance with this speculation, an *Arabidopsis* mutant deficient in CRR4, the site recognition protein of ndhD-1, cannot edit the ndhD-1 site but still possesses normal editing activity for the ndhF-1 and ndhB-3 sites ([@B8]). We should also point out that the cosuppression phenotype of RNA editing by overexpression of given editing sites could vary according to many parameters, including the relative abundance of each transcript, its affinity to *trans*-factors, and possible overlapping of *cis*-*trans* network. Suggestions from cosuppression phenotypes are important information, but require further confirmation.

In higher plant organelles, editing sites are poorly conserved among plant species. Tobacco and *Arabidopsis* chloroplast genomes have 38 and 28 editing sites, respectively, but there are only 17 overlapping sites ([@B28],[@B29],[@B34; @B35; @B36; @B37]). How has this variance occurred? This question is equal to asking how the gain and loss of editing sites has occurred during plant evolution. The apparent function of plant organellar RNA editing is to compensate for genetic mutations that alter protein-coding sequences and to restore evolutionary conserved codons at the mRNA level. Therefore, the loss of the editing sites could be easily explained by the subsequent occurrence of natural mutations that restore conserved codons ([@B40]). However, the gain of new editing sites is not easy to elucidate unless we postulate that the binding sequence of the site recognition factors have some potential latitude, as was predicted by Covello and Gray ([@B41]). [Figure 6](#F6){ref-type="fig"} illustrates a hypothetical scheme for the diversification process of plant organellar editing sites. On the condition that preexisting editing sites are recognized by their respective *trans*-acting factors, new T-to-C transitions in the organellar genome are neutral only when their upstream *cis*-sequences are recognized by preexisting *trans*-acting factors, allowing the mutated C to be converted to U at the mRNA level. This study demonstrated that, in the case of ndhB-9 and ndhF-1, 60% sequence identity in the *cis*-region between −15 and −1 is enough for such corecognition to occur. Once such corecognition occurs between preexisting and newborn editing sites, those T-to-C mutations could be stochastically fixed in the organellar genome. Figure 6.Putative diversification process of chloroplast RNA editing sites during plant evolution. T-to-C transitions are permissible when their upstream sequences are similar to those of preexisting editing sites.

The above speculative model for the proliferation and sliding of the editing sites ([Figure 6](#F6){ref-type="fig"}) predicts that RNA editing machineries of plant organelles have some potential to cope with exogenously introduced editing sites. We know that such examples exist. The spinach ndhA site I (ndhA-189) was edited when introduced into the chloroplasts of *Nicotiana tabacum* or *Nicotiana sylvestris*, although these plants do not have ndhA-189 editing sites ([@B42],[@B43]). As the immediate upstream regions (from −15 to −1) of spinach ndhA-189 and tobacco ndhF-1 share 60% sequence identity, ndhA-189 may also be recognized by p95, similarly to ndhB-9 and ndhF-1. This possibility remains to be examined.

In conclusion, this study clearly demonstrated that two RNA editing sites with *cis*-acting elements of moderate sequence identity are recognized by the same *trans*-acting factor in tobacco chloroplasts. This finding extends our knowledge that distinct proteins recognize each editing site ([@B8],[@B12],[@B14],[@B15]), and suggests that more complex *cis*-*trans* recognition networks might be operating in plant organelles.
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[^1]: Underlines indicate ribose 2′-methoxy analogs.

[^2]: NT, *Nitcotiana tabcum*; PS, *Pisum sativum*; AT, *Arabidopsis thaliana*. Names of the editing sites are according to Heyes *et al.* ([@B16]).
